Patients News | pharmaphorum

News

ABPI seeks comments on ‘future-proof’ code of practice

The body representing the UK pharma industry has published a draft 2021 code of practice, and is asking for feedback on the changes by 8 September.

News

NHS backs free behavioural change app for type 2 diabetics

NHS England has awarded a contract to tech company Changing Health to develop a free app to help the millions of people with type 2 diabetes in the UK manage their illness.

News

‘Swab-free’ coronavirus test on trial in the UK

Researchers in the UK have started testing a coronavirus test that would do away with the need to swab the nose and throat, and instead use a saliva sample that could be easily

News

Patient on hospital bed with saline solution tube

Gilead will test remdesivir in children with COVID-19

Gilead Sciences has said it will start trials soon of its antiviral drug remdesivir in children – from newborns to adolescents – who have moderate-to-severe COVID-19.

News

scientifically visualization of a coronavirus spike protein

Lilly takes AI-selected Olumiant into phase 3 for COVID-19

Eli Lilly has enrolled the first patient into a phase 3 trial that is seeking to repurpose arthritis drug Olumiant as a treatment for people with COVID-19.

News

'Major breakthrough' as cheap steroid cuts deaths in COVID-1...

The answer to improving survival rates in people with severe respiratory complications caused by COVID-19 is a generic steroid drug that can be bought for a few pounds.

ABPI seeks comments on ‘future-proof’ code of practice

NHS backs free behavioural change app for type 2 diabetics

‘Swab-free’ coronavirus test on trial in the UK

Gilead will test remdesivir in children with COVID-19

Lilly takes AI-selected Olumiant into phase 3 for COVID-19

'Major breakthrough' as cheap steroid cuts deaths in COVID-1...

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

News

Editor's Picks